NCT02681497View on ClinicalTrials.gov

Use of Canagliflozin in Conjunction With Insulin in a Real-world Setting

CompletedOBSERVATIONAL
Enrollment

269

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Type 2 Diabetes Mellitus
Trial Locations (1)

N6A 3K7

Western University, London

All Listed Sponsors
collaborator

Janssen Inc.

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT02681497 - Use of Canagliflozin in Conjunction With Insulin in a Real-world Setting | Biotech Hunter | Biotech Hunter